Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: Analysis of the korean acute myocardial infarction registry

Journal of Cardiology

Volumn 62, Issue 4, 2013, Pages 210-216

  Yamanaka, Futoshi ^a,b   Jeong, Myung Ho ^a   Saito, Shigeru ^b   Ahn, Youngkeun ^a   Chae, Shung Chull ^c   Hur, Seung Ho ^d   Hong, Taek Jong ^e   Kim, Young Jo ^f   Seong, In Whan ^g   Chae, Jei Keon ^h   Rhew, Jay Young ⁱ   Chae, In Ho ^j   Cho, Myeong Chan ^h   Bae, Jang Ho ^k   Rha, Seung Woon ^l   Kim, Chong Jin ^m   Choi, Donghoon ⁿ   Jang, Yang Soo ⁿ   Yoon, Junghan ^o   Chung, Wook Sung ^p   Cho, Jeong Gwan ^a   Seung, Ki Bae ^p   Park, Seung Jung ^q   more..

^a Chonnam National University Medical School   (South Korea)

^b Shonan Kamakura Joint Reconstruction Center   (Japan)

^c Kyungpook National University Hospital   (South Korea)

^d Dongsan Medical Center   (South Korea)

^e Pusan National University School of Medicine   (South Korea)

^f Young Nam University Hospital   (South Korea)

^g Chungnam National University College of Medicine   (South Korea)

^h Chungbuk National University Hospital   (South Korea)

ⁱ Jeonju Presbyterian Medical Center   (South Korea)

^j Seoul National University Bundang Hospital   (South Korea)

^k Konyang University   (South Korea)

^l Korea University College of Medicine   (South Korea)

^m Kyung Hee University College of Medicine   (South Korea)

ⁿ Yonsei University   (South Korea)

^o Wonju Severance Christian Hospital   (South Korea)

^p The Catholic University of Korea   (South Korea)

^q Asan Medical Center   (South Korea)

more..

Author keywords

Elderly; Myocardial infarction; Prognosis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; BLOOD CLOTTING TIME; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; HEART DISEASE; HUMAN; INCIDENCE; KOREA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OCTOGENARIAN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVASCULARIZATION; TREATMENT OUTCOME; VESSEL;

ELDERLY; MYOCARDIAL INFARCTION; PROGNOSIS; TREATMENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; GLYCOSIDES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECURRENCE; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TRITERPENES;

EID: 84885298935     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.04.003     Document Type: Article

References (26)

1. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315-1323.
3. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnàr F., Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002, 346:1773-1780.
4. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003, 362:1093-1099.
5. Schampaert E., Cohen E.A., Schluter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., Popma J.J. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004, 43:1110-1115.
6. De Gregorio J., Kobayashi Y., Albiero R., Reimers B., Di Mario C., Finci L., Colombo A. Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. J Am Coll Cardiol 1998, 32:577-583.
7. DeGeare V.S., Stone G.W., Grines L., Brodie B.R., Cox D.A., Garcia E., Wharton T.P., Boura J.A., O'Neill W.W., Grines C.L. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol 2000, 86:30-34.
8. Lindsay J., Reddy V.M., Pinnow E.E., Little T., Pichard A.D. Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty. Am Heart J 1994, 128:697-702.
9. Santana J.O., Haft J.I., LaMarche N.S., Goldstein J.E. Coronary angioplasty in patients eighty years of age or older. Am Heart J 1992, 124:13-18.
10. Hong Y.J., Jeong M.H., Abizaid A., Banning A., Bartorelli A., Dzavik V., Ellis S.G., Gao R., Holmes D.R., Legrand V., Neumann F.J., Spaulding C., Worthley S., Urban P. e-SELECT Registry Investigators. Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry. JACC Cardiovasc Interv 2011, 4:982-991.
11. Kushner F.G., Hand M., Smith S.C., King S.B., Anderson J.L., Antman E.M., Bailey S.R., Bates E.R., Blankenship J.C., Casey D.E., Green L.A., Hochman J.S., Jacobs A.K., Krumholz H.M., Morrison D.A., et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 120:2271-2306.
12. Hamm C.W., Bassand J.P., Agewall S., Bax J., Boersma E., Bueno H., Caso P., Dudek D., Gielen S., Huber K., Ohman M., Petrie M.C., Sonntag F., Uva M.S., Storey R.F., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2999-3054.
13. Apple F.S., Wu A.H., Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002, 144:981-986.
14. Devlin G., Gore J.M., Elliott J., Wijesinghe N., Eagle K.A., Avezum A., Huang W., Brieger D. GRACE Investigators. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Eur Heart J 2008, 29:1275-1282.
15. Takii T., Yasuda S., Takahashi J., Ito K., Shiba N., Shirato K., Shimokawa H. MIYAGI-AMI Study Investigators. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circulation 2010, 74:93-100.
16. Wijns W., Kolh P., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S., Huber K., James S., Knuuti J., Lopez-Sendon J., Marco J., Menicanti L., Ostojic M., Piepoli M.F., et al. Guidelines on myocardial revascularization. Eur Heart J 2010, 31:2501-2555.
17. Rittger H., Schnupp S., Sinha A.M., Breithardt O.A., Schmidt M., Zimmermann S., Mahnkopf C., Brachmann J., Rieber J. Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional vs. conservative treatment. Catheter Cardiovasc Interv 2012, 80:735-743.
18. Kelbaek H., Helqvist S., Thuesen L., Klovgaard L., Jorgensen E., Saunamaki K., Krusell L.R., Bøtker H.E., Engstrøm T., Jensen G.V. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial. Am Heart J 2006, 152:882-886.
19. Marroquin O.C., Selzer F., Mulukutla S.R., Williams D.O., Vlachos H.A., Wilensky R.L., Tanguay J.F., Holper E.M., Abbott J.D., Lee J.S., Smith C., Anderson W.D., Kelsey S.F., Kip K.E. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008, 358:342-352.
20. Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schomig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., Goy J.J., Park S.J., Sabaté M., Suttorp M.J., Kelbaek H., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007, 370:937-948.
21. Nakazawa G. Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 2011, 58:84-91.
22. Takayama T., Hiro T., Hirayama A. Stent thrombosis and drug-eluting stents. J Cardiol 2011, 58:92-98.
23. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrie D., Slama M.S., Merkely B., Erglis A., Margheri M., Varenne O., Cebrian A., Stoll H.P., Snead D.B., Bode C. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006, 355:1093-1104.
24. Violini R., Musto C., De Felice F., Nazzaro M.S., Cifarelli A., Petitti T., Fiorilli R. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial. J Am Coll Cardiol 2010, 55:810-814.
25. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., Cacoub P., Cohen E.A., Creager M.A., Easton J.D., Flather M.D., Haffner S.M., Hamm C.W., Hankey G.J., Johnston S.C., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, 354:1706-1717.
26. Damman P., Iniguez A., Klomp M., Beijk M., Woudstra P., Silber S., Ribeiro E.E., Suryapranata H., Sim K.H., Tijssen J.G., de Winter R.J. e-HEALING investigators. Coronary stenting with the Genous Bio-Engineered R Stent in elderly patients. Circ J 2011, 75:2590-2597.